Resveratrol inhibits the expression and function of the androgen receptor in LNCaP prostate cancer cells

Cancer Research

Volumn 59, Issue 23, 1999, Pages 5892-5895

  Mitchell, Susan H ^a   Zhu, Wen ^b   Young, Charles Y F ^a  

^a MAYO CLINIC   (United States)

^b MAYO GRADUATE SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; CYCLIN DEPENDENT KINASE INHIBITOR; KALLIKREIN; MESSENGER RNA; PROSTATE SPECIFIC ANTIGEN; PROTEIN; RESVERATROL;

ARTICLE; CANCER CELL; CANCER CHEMOTHERAPY; CELL GROWTH; DRUG EFFECT; GENE CONTROL; GENE EXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN ANALYSIS; PROTEIN EXPRESSION; TRANSCRIPTION REGULATION;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; ENZYME INHIBITORS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; ONCOGENE PROTEINS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RECEPTORS, ANDROGEN; RNA, MESSENGER; STILBENES; TISSUE KALLIKREINS; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED; UP-REGULATION;

EID: 0033435221     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Hovenian, M. S., and Deming, C. L. The heterologous growth of cancer of the human prostate. Surg. Gynecol. Obstet., 86: 29-35, 1948.
2. Ross, R. K., Bernstein, L., Judd, H., Hanisch, R., Pike, M., and Henderson, B. Serum testosterone levels in young black and white men. J. Natl. Cancer Inst., 76: 45-48, 1986.
3. Evans, R. M. The steroid and thyroid hormone receptor superfamily. Science (Washington DC), 240: 889-895, 1988.
4. Aquilina, J. W., Lipsky, J. J., and Bostwick, D. G. Androgen deprivation as a strategy for prostate cancer chemoprevention. J. Natl. Cancer Inst., 89: 689-696, 1997.
5. Jang, M., Cai, L., Udeani, G. O., Slowing, K. V., Thomas, C. F., Beecher, C. W. W., Fong, H. H. S., Farnsworth, N. R., Kinghorn, A. D., Mehta, R. G., Moon, R. C., and Pezzuto, J. M. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science (Washington DC), 275: 218-220, 1997.
6. Subbaramaiah, K., Chung, W. J., Michaluart, P., Telang, N., Tanabe, T., Inoue, H., Jang, M., Pezzuto, J. M., and Dannenberg, A. J. Resveratrol inhibits cyclooxygenase-2 transcription and activity in phorbol ester-treated human mammary epithelial cells. J. Biol. Chem., 273: 21875-21882, 1998.
7. Zhang, S., Hsieh, M. L., Zhu, W., Klee, G. G., Tindall, D. J., Young, C. Y. F. Interactive effects of triiodothyronine and androgens on prostate cell growth and gene expression. Endocrinology, 140: 1665-1671, 1999
8. Chomczynski, P., and Sacchi, N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162: 156-159, 1987.
9. Young, C. Y. F., Murtha, P. E., and Zhang, J. Tumor-promoter phorbol ester-induced cell death and gene expression in a human prostate adenocarcinoma cell line. Oncol. Res., 6: 203-210, 1994.
10. Horoszwicz, J. S., Leoung, S. S., Kawinski, E., Karr, J. P., Rosenthal, H., Chu, T. M., Mirand, E. A., and Murphy, G. P. LNCaP model of human prostatic carcinoma. Cancer Res., 43: 1809-1818, 1983.
11. Pendurthi, U. R., Williams, J. T., and Rao, L. V. M. Resveralrol, a polyphenolic compound found in wine, inhibits tissue factor expression in vascular cells a possible mechanism for the cardiovascular benefits associated with moderate consumption of wine. Arterioscler. Thromb. Vasc. Biol., 19: 419-426, 1999.
12. Gregory, C. W., Hamil, K. G., Kim, D., Hall, S. H., Pretlow, T. G., Mohler, J. L., and French, F. S. Androgen receptor expression in androgen-independent prostate cancer is associated with increased expression of androgen-regulated genes. Cancer Res., 58: 5718-5724, 1998.
13. Yeh, S., and Chang, C. Cloning and characterization of a specific coactivator, ARA70. for the androgen receptor in human prostate cells. Proc. Natl. Assoc. Sci. USA, 93: 5517-5521, 1996.
14. Miyamoto, H., Yeh, S., Wilding, G., and Chang, C. Promotion of agonist activity of antiandrogens by the androgen receptor coactivator, ARA70, in human prostate cancer DU145 cells. Proc. Natl. Assoc. Sci. USA, 95: 7379-7384, 1998.
15. Lu, S., Liu, M., Epner, D. E., Tsai, S. Y., and Tsai, M. J. Androgen regulation of the cyclin dependent kinase inhibitor p21 gene through an androgen response element in the proximal promoter. Mol. Endocrinol., 13: 376-384, 1999.
16. Levkar, B., Koyama, H., Raines, E. W., Clurman, B. E., Herren, B., Orth, K., Roberts, J. M., and Ross, R. Cleavage of p21Cip1/Waf1 and p27 Kip1 mediates apoptosis in endothelial cells through activation of cdk2: role of caspase cascade. Mol. Cell, 1: 553-563, 1998.
17. Gorospe, M., Wang, X., Guyton, K. Z., and Holbrook, N. J. Protective role of p21 Waf1/Cip1 against prostaglandin A2-mediated apoptosis of human colorectal carcinoma cells. Mol. Cell. Biol., 16: 6654-6660, 1996.
18. Imperato-McGinley, J., Guerrero, L., Gautier, T., and Peterson, R. E. Steroid 5α-reductase deficiency in man: an inherited form of male pseudohermaphroditism. Science (Washington DC), 186: 1213-1215, 1974.
19. Wilding, G. Endocrine control of prostate cancer. Cancer Surv., 23: 43-62, 1995.
20. Yang, C. S. Inhibition of carcinogenesis by tea. Nature (Lond.), 389: 134-135, 1997.
21. Gupta, S., Ahmad, N., Mohan, R. R , Husain, M. M., and Mukhtar, H. Prostate cancer chemoprevention by green tea: in vitro and in vivo inhibition of testosterone-mediated induction of ornithine decarboxylase. Cancer Res., 59: 2115-2120, 1999.